Most Infants Are Well Even When Moms are Infected by COVID-19
Infants born to women with COVID-19 showed few adverse outcomes, according to the first report in the country of infant outcomes through eight weeks of age.
University of California San Francisco
Give to UCSF
Maternal Stress During Pregnancy Linked to Infant Illness
Greater maternal stress during pregnancy is linked with significant increases in the number and variety of infant illness during the first year of life, independent of the level of stress after birth.
Female Chromosomes Offer Resilience to Alzheimer’s
UCSF scientists now have evidence from research that women with Alzheimer’s live longer than men with the disease because they have genetic protection from the ravages of the disease.
New Model of Breast Cancer’s Causes Developed by UCSF-led Team
A new model of the causes of breast cancer, created by a team led by researchers at UCSF, Genentech and Stanford University, is designed to capture the complex interrelationships between dozens of primary and secondary breast cancer causes and stimulate further research.
Pregnant Women with Fatty Liver Disease Face Worse Outcomes
Pregnant women with the metabolic condition known as non-alcoholic fatty liver disease have more than four times the risk of serious adverse maternal-fetal outcomes.
Microbiome Therapy Protects Against Recurrent Bacterial Vaginosis
A product containing healthy vaginal bacteria has proved effective against recurrent bacterial vaginosis (BV), an extremely common vaginal infection that is associated with preterm birth, HIV infection and problems with in vitro fertilization.
Elena Fuentes-Afflick Elected to American Academy of Arts and Sciences
UCSF pediatrician and epidemiologist, Elena Fuentes-Afflick, MD, MPH, has been elected to the American Academy of Arts and Sciences, which honors exceptional scholars, leaders, artists and innovators. Fuentes-Afflick’s research has focused on the issues of acculturation, immigrant health and health disparities.
Confronting COVID-19: Donors’ Generosity Put to Use at Lightning Speed Across UCSF
Vigorously embracing their leadership roles, our faculty members are coming together to tackle this public health crisis from all angles.
What We Know and Don’t Know About Coronavirus and Pregnancy
Pregnant women are at higher risk for many infections, but the risks of COVID-19 to mother and baby are not yet clear. UCSF experts share what we know and don’t know about COVID-19’s effects on pregnancy, the possibility of in utero transmission, and advice for pregnant women.
National Paid Maternity Leave Makes Sense for Mothers, Babies and Maybe the Economy
New mothers who are entitled to paid maternity leave beyond a few weeks’ duration are more likely to have better mental and physical health.
Scientists Unravel Mystery of Rare Genetic Disorder that Causes Intellectual Disability in Females
UCSF scientists have made a significant advance toward understanding a rare genetic condition, almost exclusively affecting females, that results in a broad spectrum of neurodevelopmental deficits.
In Utero Stem Cell Transplants, Enzyme Replacement May Offer New Treatments for Deadly Metabolic Disorders
Administering stem cell or enzyme therapy in utero may be a path to alleviating some congenital diseases that often result in losing a pregnancy, according to a new study in mice by UCSF researchers. They showed that stem cells can enter the fetal brain during prenatal development and make up for cells that fail to make an essential protein.
